Showing 1 - 4 results of 4 for search 'Elizabeth M Batty', query time: 0.01s Refine Results
  1. 1
    Case Report: Genetic evolution of Burkholderia pseudomallei during treatment leading to antibiotic resistance and disease relapse. [version 2; peer review: 2 approved]

    Case Report: Genetic evolution of Burkholderia pseudomallei during treatment leading to antibiotic resistance and disease relapse. [version 2; peer review: 2 approved] by Ko Chang, Elizabeth A. Ashley, Claire Chewapreecha, Anousone Douangnouvong, Chantisa Keeratipusana, Terry John Evans, Koukeo Phommasone, Davanh Sengdatka, Elizabeth M. Batty, Vilayouth Phimolsarnnousith

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Long-read whole genome sequencing and comparative analysis of six strains of the human pathogen Orientia tsutsugamushi.

    Long-read whole genome sequencing and comparative analysis of six strains of the human pathogen Orientia tsutsugamushi. by Elizabeth M Batty, Suwittra Chaemchuen, Stuart Blacksell, Allen L Richards, Daniel Paris, Rory Bowden, Caroline Chan, Ramkumar Lachumanan, Nicholas Day, Peter Donnelly, Swaine Chen, Jeanne Salje

    Published 2018-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A modified RNA-Seq approach for whole genome sequencing of RNA viruses from faecal and blood samples.

    A modified RNA-Seq approach for whole genome sequencing of RNA viruses from faecal and blood samples. by Elizabeth M Batty, T H Nicholas Wong, Amy Trebes, Karène Argoud, Moustafa Attar, David Buck, Camilla L C Ip, Tanya Golubchik, Madeleine Cule, Rory Bowden, Charis Manganis, Paul Klenerman, Eleanor Barnes, A Sarah Walker, David H Wyllie, Daniel J Wilson, Kate E Dingle, Tim E A Peto, Derrick W Crook, Paolo Piazza

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)Research in context

    Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)Research in context by Podjanee Jittamala, Simon Boyd, William H.K. Schilling, James A. Watson, Thundon Ngamprasertchai, Tanaya Siripoon, Viravarn Luvira, Elizabeth M. Batty, Phrutsamon Wongnak, Lisia M. Esper, Pedro J. Almeida, Cintia Cruz, Fernando R. Ascencao, Renato S. Aguiar, Najia K. Ghanchi, James J. Callery, Shivani Singh, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Wanassanan Madmanee, Kanokon Suwannasin, Amornrat Promsongsil, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Manus Potaporn, Attasit Srisubat, Bootsakorn Loharjun, Walter R.J. Taylor, Farah Qamar, Abdul Momin Kazi, M. Asim Beg, Danoy Chommanam, Sisouphanh Vidhamaly, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas P.J. Day, Mauro M. Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J. White

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: